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SurgicalSolutions
Thoracic & Esophageal Surgery
Program Combines Nationwide Expertise
with Robotic, Telehealth Innovations
focused on Thoracic Outlet Syndrome.
Common among athletes, this condition
may develop when the muscles at the
top of the chest become so enlarged
that they pinch the nerves, arteries and
veins coming out of the chest.

Our surgeons use the da Vinci® Surgical System, which provides a magnified, high-definition 3-D image of the
patient’s anatomy and translates the surgeon’s hand movements into precise micro-movements.

The Jefferson Thoracic & Esophageal
Surgery Program offers a full range of
services with an emphasis on robotic
procedures (90% of cases) – increasing
the likelihood of a shorter hospital stay
and a faster overall recovery. Led by
Nathaniel R. Evans III, MD, the Program
is comprised of surgeons Scott W.
Cowan, MD, Tyler R. Grenda, MD, MS,
and Olugbenga T. Okusanya, MD, as
well as nurse practitioner, Sung E.
Whang, DNP, CRNP.
Robotic approaches can be especially
beneficial for lung cancer patients.
When performing lobectomies and
segmentectomies with this technology,
surgeons are able to spare more
healthy lung tissue.
“These techniques provide patients
optimal breathing function after
surgery,” Dr. Evans explains. The team
also uses robotic methods to treat
esophageal cancer and hiatal hernias,
including very large hernias of the
stomach into the chest.
The Program is part of an enterprise
multidisciplinary group, which includes
gastroenterologists and general
surgeons and looks at all types of
complex esophageal cancer, as well
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as benign esophageal diseases and
conditions, such as reflux and hiatal
hernias.

Along with robotics,
the Program has also
been an early adopter of
telemedicine. Even before
the COVID-19 pandemic,
the team led the way
in using virtual visits to
engage with patients.
Dr. Evans notes that one of the
Program’s strengths is the diversity of
its team’s education and experience.
Having been trained at institutions
from coast to coast, these surgeons
bring perspectives from some of the
largest thoracic surgery programs in
the country. For example, Dr. Grenda is
an expert in revision foregut surgery –
that is, correcting previously treated
hernias that recur a second or third
time. In addition, Dr. Okusanya came to
Jefferson from the nation’s leading
Minimally Invasive Esophagectomy
program and is also initiating a program

Along with robotics, the Program
has also been an early adopter of
telemedicine. Even before the
COVID-19 pandemic, the team led the
way in using virtual visits to engage with
patients. In 2018, Dr. Whang received
the JeffConnect Healthcare Delivery &
Quality Transformation Award for
facilitating 149 video visits with post-op
patients over a 12-month period.
“Because of that early experience,
it was easy for us to transition fully to
telehealth visits earlier this year,” Dr.
Evans says, adding that the program
completed 567 telehealth visits from
mid-March to mid-December. Dr.
Grenda reported that experience in the
August 2020 issue of the Annals of
Surgery.
“There were multiple patients that we
‘met’ via video visit to review the plan
and the imaging studies that needed
to be done prior to their surgery. We
wouldn’t physically meet them until
the day of the surgery.”
One such patient first presented in
the Emergency Department with
COVID-19. Only through that diagnosis
was she found to have lung cancer.
After a virtual visit with Dr. Evans, she
was scheduled for a robotic right upper
lobectomy – a procedure that
successfully removed the cancerous
tissue and confirmed she had stage
IIB disease. She spent just one night
in the hospital and following an
uncomplicated recovery, she was
treated with adjuvant therapy.
To schedule an appointment with a
thoracic surgeon or refer a patient,
please call 215-955-5562.
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The Surgeon Speaks

“Our team is committed to exploring and
adopting new and better ways of caring
for our patients. That’s evident both in the
surgical techniques we use and the ways in
which we engage with patients.
It’s also clear in our research priorities.
One example is a recent clinical trial on
immunotherapy for early-stage lung cancer.
This represents the new frontier for
immunotherapy, which currently focuses
on metastatic or late-stage disease.
In another study, we’re collecting lung
cancer samples to explore the potential to
create a blood test for lung cancer. This
involves drawing blood from patients with
and without lung cancer and then assessing
their micro-RNA to identify potential signs
of cancer.
We’re being mindful to include patients of
all ethnic backgrounds to ensure our results
are applicable to the real-world – including
the diverse base of patients that we care for
at Jefferson.”
Nathaniel R. Evans III, MD
Professor of Surgery
Director, Division of Thoracic &
Esophageal Surgery

For more information, please visit:
JeffersonHealth.org/Korman

Clinical Integration
General Surgery Continues Journey as Enterprise Service Line
– Page 3
Those Who Give
Swoyers Support Colorectal Cancer Vaccine Research
– Page 4

